Clinical Practice Guidelines

IEHP develops and maintains clinical practice guidelines as standards of health care applicable to members and providers. The IEHP Quality Management Committee delegates responsibility for developing, reviewing, and maintaining clinical practice guidelines to the IEHP Standards Subcommittee. The QM Committee performs final approval and adoption of all guidelines. Clinical practice guidelines requiring pharmaceutical management are initiated and investigated through the Pharmacy and Therapeutics (PT) Subcommittee prior to review by the Standards Subcommittee.

All clinical practice guidelines are based on scientific evidence, review of the medical literature, or appropriately established authority, as cited. All recommendations are based on published consensus guidelines (National Guideline Clearinghouse) and do not favor any particular treatment based solely on cost considerations.

The recommendations for care are suggested as guides for making clinical decisions. Clinicians and their patients must work together to develop individual treatment plans that are tailored to the specific needs and circumstances of each patient.

  • Asthma Care Quick Reference - NHLBI EPR 3View »

  • Attention Deficit Hyperactivity Disorder - Pediatrics (Effective Oct ,1 2018)View »

  • Behavioral Health Integration and Complex Care Initiative–Cholesterol Screening and MonitoringView »

  • Behavioral Health Integration and Complex Care Initiative–Diabetes Mellitus IIView »

  • Behavioral Health Integration and Complex Care Initiative–Hypertension Screening and MonitoringView »

  • Behavioral Health Integration and Complex Care Initiative – Major DepressionView »

  • Cardiovascular Health and Risk Reduction in Children and AdolescentsView »

  • Chronic Kidney DiseaseView »

  • Chronic Kidney Disease and DiabetesView »

  • Chronic Obstructive Pulmonary Disease COPDView »

  • Depression - Adolescent (Effective Oct 1, 2018)View »

  • Depression - Adolescent Tool KitView »

  • Depression - Major Depressive Disorder (Effective Oct 1, 2018)View »

  • Diabetes Mellitus - ADAView »

  • Diabetes PregnancyView »

  • Fibromyalgia (Effective Oct 1, 2018)View »

  • Gastroesophageal Reflux Disease - AdultsView »

  • Gastroesophageal Reflux Disease - PediatricsView »

  • Hepatitis C AASLDView »

  • Hyperlipidemia - ACC/AHAView »

  • HypertensionView »

  • Hypertension ACCView »

  • IVIG - Intravenous Immunoglobulin in the Treatment of Neuromuscular Disorders (Effective Oct 1, 2018)View »

  • Migraine - Pharmacologic Treatment for Episodic Migraine Prevention in Adults (Effective Oct 1,2018)View »

  • Multiple Sclerosis (Effective Oct 1, 2018)View »

  • Osteoarthritis - Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip and Knee (Effective Oct , 2018)View »

  • Pain Management (Effective Oct 1, 2018)View »

  • Pain Quick Reference GuideView »

  • Psychotropic Medication Use with Children and Youth in Foster Care (Effective Oct 1, 2018)View »

  • Pulmonary Arterial HypertensionView »

  • Respiratory Syncytial Virus (Effective Oct 1, 2018)View »

  • Rheumatoid Arthritis (Effective Oct 1, 2018)View »

  • Sexually Transmitted Diseases - Summary of CDC Treatment Guidelines (Effective Oct 1 2018)View »

  • Smoking Cessation (Effective Oct 1, 2018)View »